Prothena Announces Leadership Team Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
Prothena Corp (PRTA) PT Lowered to $31 at BofA Securities
October 1, 2024 6:05 AM EDTBofA Securities analyst Tazeen Ahmad lowered the price target on Prothena Corp (NASDAQ: PRTA) to $31.00 (from $33.00) while maintaining a Neutral rating.
The analyst comments "We connected with management following the late Friday announcement that CMO, Hideki Garren, MD, PhD was leaving the company. Garren joined Roche as the new head of Neurology Product Development. CEO Gene Kinney stated that Garren has created a strong team at Prothena (PRTA). The company... More
